OTCMKTS:GNCP

GNCC Capital Stock Forecast, Price & News

$0.0020
0.00 (0.00 %)
(As of 05/10/2021 12:00 AM ET)
Add
Compare
Today's Range
$0.00
$0.00
50-Day Range N/A
52-Week Range
$0.00
$0.00
Volume510.11 million shs
Average Volume431.75 million shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
30 days | 90 days | 365 days | Advanced Chart
Receive GNCP News and Ratings via Email

Sign-up to receive the latest news and ratings for GNCC Capital and its competitors with MarketBeat's FREE daily newsletter.


GNCC Capital logo

About GNCC Capital

GNCC Capital, Inc. through its subsidiary, BioCann Pharma S.A.S., produces and sells cannabis CBD pharmaceutical grade oils. It sells its products through distribution channels in Colombia and throughout Latin America. The company is based in Las Vegas, Nevada.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry Gold
Sub-IndustryN/A
Current SymbolOTCMKTS:GNCP
CUSIPN/A
CIKN/A
Phone702 990 0156
EmployeesN/A
Year FoundedN/A

Sales & Book Value

Annual SalesN/A

Profitability

Debt

Price-To-Earnings

Miscellaneous

Next Earnings DateN/A
OptionableNot Optionable

MarketRank

Overall MarketRank

0.00 out of 5 stars

Basic Materials Sector

779th out of 856 stocks

Gold Industry

85th out of 91 stocks

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











GNCC Capital (OTCMKTS:GNCP) Frequently Asked Questions

What stocks does MarketBeat like better than GNCC Capital?

Wall Street analysts have given GNCC Capital a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but GNCC Capital wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Who are GNCC Capital's key executives?

GNCC Capital's management team includes the following people:
  • Mr. Ronald Yadin Lowenthal, Exec. Chairman (Age 73)
  • Mr. Nicolaas Edward Blom, CEO, Pres, CFO, Sec. & Director (Age 62)

Who are some of GNCC Capital's key competitors?

What other stocks do shareholders of GNCC Capital own?

Based on aggregate information from My MarketBeat watchlists, some companies that other GNCC Capital investors own include KushCo (KSHB), (KDMN), Isracann Biosciences (ISCNF), HIVE Blockchain Technologies (HIVE), Foresight Autonomous (FRSX), Draganfly (DFLYF), Cellectar Biosciences (CLRB), BioTech Medics (BMCS), Blink Charging (BLNK) and Big Tree Group (BIGG).

What is GNCC Capital's stock symbol?

GNCC Capital trades on the OTCMKTS under the ticker symbol "GNCP."

How do I buy shares of GNCC Capital?

Shares of GNCP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is GNCC Capital's stock price today?

One share of GNCP stock can currently be purchased for approximately $0.00.

What is GNCC Capital's official website?

The official website for GNCC Capital is www.gncc-capital.com.

How can I contact GNCC Capital?

The company can be reached via phone at 702 990 0156.


This page was last updated on 5/11/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.